Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma.
- DOI
- 10.1158/2159-8290.cd-14-0098
- Published
- 2014 Sep
- Container
- Cancer discovery
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/2159-8290.cd-14-0098,
title = {Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma.},
author = {Chiron D and Di Liberto M and Martin P and Huang X and Sharman J and Blecua P and Mathew S and Vijay P and Eng K and Ali S and Johnson A and Chang B and Ely S and Elemento O and Mason CE and Leonard JP and Chen-Kiang S},
year = {2014},
journal = {Cancer discovery},
doi = {10.1158/2159-8290.cd-14-0098},
url = {https://doi.org/10.1158/2159-8290.cd-14-0098}
}RIS
TY - JOUR TI - Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma. AU - Chiron D AU - Di Liberto M AU - Martin P AU - Huang X AU - Sharman J AU - Blecua P AU - Mathew S AU - Vijay P AU - Eng K AU - Ali S AU - Johnson A AU - Chang B AU - Ely S AU - Elemento O AU - Mason CE AU - Leonard JP AU - Chen-Kiang S PY - 2014 JO - Cancer discovery DO - 10.1158/2159-8290.cd-14-0098 UR - https://doi.org/10.1158/2159-8290.cd-14-0098 ER -
APA
D, C., M, D. L., P, M., X, H., J, S., P, B., S, M., P, V., K, E., S, A., A, J., B, C., S, E., O, E., CE, M., JP, L., & S, C. (2014). Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma.. Cancer discovery. https://doi.org/10.1158/2159-8290.cd-14-0098
Source records
- pubmed · retrieved 2026-09-25T05:29:43.892Z